
Join to View Full Profile
1515 Holcombe BlvdHouston, TX 77030
Phone+1 713-792-6161
Dr. Chapin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Mass General Brigham/Massachusetts General Hospital/Harvard Medical SchoolResidency, Urology, 2006 - 2010
- Mass General Brigham/Massachusetts General HospitalResidency, Surgery, 2004 - 2006
- Georgetown University School of MedicineClass of 2004
Certifications & Licensure
- FL State Medical License 2021 - Present
- AZ State Medical License 2023 - 2026
- MS State Medical License 2023 - 2026
- OK State Medical License 2020 - 2026
- TN State Medical License 2023 - 2026
- TX State Medical License 2010 - 2026
- WA State Medical License 2023 - 2026
- American Board of Urology Urology
- Join now to see all
Clinical Trials
- Best Systemic Therapy or Best Systemic Therapy (BST) Plus Definitive Treatment (Radiation or Surgery) Start of enrollment: 2013 Mar 18
- NeoAdjuvant Theranostic Lutetium Study: The Nautilus Trial Start of enrollment: 2024 Mar 29
Roles: Contact
Publications & Presentations
PubMed
- Continuous Androgen Deprivation Therapy with or Without Metastasis-directed Therapy for Oligometastatic Prostate Cancer: The Multicenter Phase 2 Randomized EXTEND Trial.Alexander D Sherry, Bilal A Siddiqui, Cara Haymaker, Bryan M Fellman, Marina N Medina-Rosales
European Urology. 2025-07-31 - Randomized Phase 2 Trial of Presurgical Androgen Deprivation Therapy With or Without Axitinib in Prostate Cancer Presenting With Lymph Node Metastasis.Amado J Zurita, Rebecca S Tidwell, Brian F Chapin, Deborah R Harris, Miao Zhang
European Urology Oncology. 2025-07-11 - GLP-1 Agonist Use Among Men With Localized Prostate Cancer: A Narrative Review and Rationale for Prospective Clinical Trials.Andrew Fang, Daniel E Frigo, Andrew Hahn, Zayd Razouki, Jessica Hwang
Urology. 2025-07-01
Lectures
- Complex biologic heterogeneity of de novo hormone naïve metastatic prostate cancer (HNPCa): Comparison of early progressors and prolonged responders to initial system...2019 ASCO Annual Meeting - 6/1/2019
- 7th Urologic Oncology: Advances in Clinical PracticeThe University of Texas, M. D. Anderson Cancer Center, Houston, Texas - 11/2/2012
Press Mentions
- 2021 Urology Care Foundation Research Scholar Awardees AnnouncedApril 13th, 2021
- Two-Time Cancer Survivor: MD Anderson Is Helping Me Beat the OddsDecember 1st, 2020
- Preoperative mpMRI Possibly Beneficial in High-Risk Prostate CancerSeptember 16th, 2019
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: